Hearing Loss Treatment
Jan 10, 2024
Ears to the Future: Evaluating Key Advancements and Trends Driving the Audiology Devices Market Growth
Audiology Devices have witnessed an unprecedented surge in demand in recent years. One of the primary drivers is the escalating prevalence of hearing impairments globally, attributed to various factors such as an aging population and increased exposure to environmental noise. As per the World Health Organization (W...
Read More...
Nov 08, 2022
Amgen’s Olpasiran Candidate; GSK’s Novel Antibiotic for Urinary Tract Infections; AstraZeneca and Sanofi’s Beyfortus Approval; FDA Orphan Designation to Anavex’s Anavex2-73; FDA Rare Pediatric Disease Designation to Sensorion’s OTOF-GT; GSK’s Blenrep Fails in Phase III Trial in R/R Multiple Myeloma
Amgen Reports Promising Mid-stage Results for its Olpasiran Candidate Amgen has reported encouraging mid-stage results for its olpasiran candidate for lowering lipoprotein(a) - a risk factor for atherosclerotic cardiovascular disease - and now plans to move forward with a phase III program as soon as possi...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
